A study of seven GBM patient tumor samples showed that nearly half of the GBM tumors examined were infiltrated by CD4+ T cells expressing CD56, an NK cell marker, and the frequency of CD56+CD4+ T cells was much higher than in meningiomas and metastatic lung cancers [153]. The gene discussed is CD4; the disease is meningioma.